The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Papillomavirus Vaccine Market Research Report 2025
Synopsis
Human papilloma virus (HPV) vaccine is a vaccine that prevents infection by certain types of human papillomavirus.
The global Human Papillomavirus Vaccine market was valued at US$ 2154.1 million in 2023 and is anticipated to reach US$ 2699.8 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Human Papillomavirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Papillomavirus Vaccine.
Report Scope
The Human Papillomavirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Papillomavirus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Papillomavirus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
GlaxoSmithKline
Sanofi
Johnson & Johnson
AstraZeneca
Serum Institute
Wantai Biological
KM Biologics
Bharat Biotech
Segment by Type
Bivalent
Quadrivalent
Nonavalent
Segment by Application
Cervical Cancer
Anal Cancer
Penile Cancer
Oropharyngeal Cancer
Genital Warts
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Papillomavirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Papillomavirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Human papilloma virus (HPV) vaccine is a vaccine that prevents infection by certain types of human papillomavirus.
The global Human Papillomavirus Vaccine market was valued at US$ 2154.1 million in 2023 and is anticipated to reach US$ 2699.8 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Human Papillomavirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Papillomavirus Vaccine.
Report Scope
The Human Papillomavirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Papillomavirus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Papillomavirus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
GlaxoSmithKline
Sanofi
Johnson & Johnson
AstraZeneca
Serum Institute
Wantai Biological
KM Biologics
Bharat Biotech
Segment by Type
Bivalent
Quadrivalent
Nonavalent
Segment by Application
Cervical Cancer
Anal Cancer
Penile Cancer
Oropharyngeal Cancer
Genital Warts
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Papillomavirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Papillomavirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Human Papillomavirus Vaccine Market Overview
1.1 Product Overview and Scope of Human Papillomavirus Vaccine
1.2 Human Papillomavirus Vaccine Segment by Type
1.2.1 Global Human Papillomavirus Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Bivalent
1.2.3 Quadrivalent
1.2.4 Nonavalent
1.3 Human Papillomavirus Vaccine Segment by Application
1.3.1 Global Human Papillomavirus Vaccine Market Value by Application: (2024-2030)
1.3.2 Cervical Cancer
1.3.3 Anal Cancer
1.3.4 Penile Cancer
1.3.5 Oropharyngeal Cancer
1.3.6 Genital Warts
1.3.7 Others
1.4 Global Human Papillomavirus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Human Papillomavirus Vaccine Revenue 2019-2030
1.4.2 Global Human Papillomavirus Vaccine Sales 2019-2030
1.4.3 Global Human Papillomavirus Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Human Papillomavirus Vaccine Market Competition by Manufacturers
2.1 Global Human Papillomavirus Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Human Papillomavirus Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Human Papillomavirus Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Human Papillomavirus Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Papillomavirus Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Papillomavirus Vaccine, Product Type & Application
2.7 Human Papillomavirus Vaccine Market Competitive Situation and Trends
2.7.1 Human Papillomavirus Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Papillomavirus Vaccine Players Market Share by Revenue
2.7.3 Global Human Papillomavirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Papillomavirus Vaccine Retrospective Market Scenario by Region
3.1 Global Human Papillomavirus Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Human Papillomavirus Vaccine Global Human Papillomavirus Vaccine Sales by Region: 2019-2030
3.2.1 Global Human Papillomavirus Vaccine Sales by Region: 2019-2024
3.2.2 Global Human Papillomavirus Vaccine Sales by Region: 2025-2030
3.3 Global Human Papillomavirus Vaccine Global Human Papillomavirus Vaccine Revenue by Region: 2019-2030
3.3.1 Global Human Papillomavirus Vaccine Revenue by Region: 2019-2024
3.3.2 Global Human Papillomavirus Vaccine Revenue by Region: 2025-2030
3.4 North America Human Papillomavirus Vaccine Market Facts & Figures by Country
3.4.1 North America Human Papillomavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Human Papillomavirus Vaccine Sales by Country (2019-2030)
3.4.3 North America Human Papillomavirus Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Papillomavirus Vaccine Market Facts & Figures by Country
3.5.1 Europe Human Papillomavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Human Papillomavirus Vaccine Sales by Country (2019-2030)
3.5.3 Europe Human Papillomavirus Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Papillomavirus Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Human Papillomavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Human Papillomavirus Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Human Papillomavirus Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Papillomavirus Vaccine Market Facts & Figures by Country
3.7.1 Latin America Human Papillomavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Human Papillomavirus Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Human Papillomavirus Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Papillomavirus Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Papillomavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Human Papillomavirus Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Human Papillomavirus Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Human Papillomavirus Vaccine Sales by Type (2019-2030)
4.1.1 Global Human Papillomavirus Vaccine Sales by Type (2019-2024)
4.1.2 Global Human Papillomavirus Vaccine Sales by Type (2025-2030)
4.1.3 Global Human Papillomavirus Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Human Papillomavirus Vaccine Revenue by Type (2019-2030)
4.2.1 Global Human Papillomavirus Vaccine Revenue by Type (2019-2024)
4.2.2 Global Human Papillomavirus Vaccine Revenue by Type (2025-2030)
4.2.3 Global Human Papillomavirus Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Human Papillomavirus Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Human Papillomavirus Vaccine Sales by Application (2019-2030)
5.1.1 Global Human Papillomavirus Vaccine Sales by Application (2019-2024)
5.1.2 Global Human Papillomavirus Vaccine Sales by Application (2025-2030)
5.1.3 Global Human Papillomavirus Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Human Papillomavirus Vaccine Revenue by Application (2019-2030)
5.2.1 Global Human Papillomavirus Vaccine Revenue by Application (2019-2024)
5.2.2 Global Human Papillomavirus Vaccine Revenue by Application (2025-2030)
5.2.3 Global Human Papillomavirus Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Human Papillomavirus Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Human Papillomavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Human Papillomavirus Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Human Papillomavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GlaxoSmithKline Human Papillomavirus Vaccine Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Human Papillomavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi Human Papillomavirus Vaccine Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Human Papillomavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson Human Papillomavirus Vaccine Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Human Papillomavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AstraZeneca Human Papillomavirus Vaccine Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Serum Institute
6.6.1 Serum Institute Corporation Information
6.6.2 Serum Institute Description and Business Overview
6.6.3 Serum Institute Human Papillomavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Serum Institute Human Papillomavirus Vaccine Product Portfolio
6.6.5 Serum Institute Recent Developments/Updates
6.7 Wantai Biological
6.6.1 Wantai Biological Corporation Information
6.6.2 Wantai Biological Description and Business Overview
6.6.3 Wantai Biological Human Papillomavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Wantai Biological Human Papillomavirus Vaccine Product Portfolio
6.7.5 Wantai Biological Recent Developments/Updates
6.8 KM Biologics
6.8.1 KM Biologics Corporation Information
6.8.2 KM Biologics Description and Business Overview
6.8.3 KM Biologics Human Papillomavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 KM Biologics Human Papillomavirus Vaccine Product Portfolio
6.8.5 KM Biologics Recent Developments/Updates
6.9 Bharat Biotech
6.9.1 Bharat Biotech Corporation Information
6.9.2 Bharat Biotech Description and Business Overview
6.9.3 Bharat Biotech Human Papillomavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bharat Biotech Human Papillomavirus Vaccine Product Portfolio
6.9.5 Bharat Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Papillomavirus Vaccine Industry Chain Analysis
7.2 Human Papillomavirus Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Papillomavirus Vaccine Production Mode & Process
7.4 Human Papillomavirus Vaccine Sales and Marketing
7.4.1 Human Papillomavirus Vaccine Sales Channels
7.4.2 Human Papillomavirus Vaccine Distributors
7.5 Human Papillomavirus Vaccine Customers
8 Human Papillomavirus Vaccine Market Dynamics
8.1 Human Papillomavirus Vaccine Industry Trends
8.2 Human Papillomavirus Vaccine Market Drivers
8.3 Human Papillomavirus Vaccine Market Challenges
8.4 Human Papillomavirus Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
